T-Vec plus Pembro phase 1b
Update on Phase 1b study
We've been waiting for this one .
T-Vec alone wasn't convincing in the past but this is the combination with Pembro.
Treatment naive patients, 20% Braf pos
Flat dose 200 mg Pembro Q2W used
Side effects typical for immune therapy
Well-tolerated
Unfortunately NO COMMENT on response rates!!!!
Next step: will be tested in a Phase 3 trial
No comments:
Post a Comment